PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway
Abstract Background Glucocorticoid (GC)-associated osteonecrosis of the femoral head (ONFH) is the most common in non-traumatic ONFH. Despite a strong relationship between GC and ONFH, the detailed mechanisms have remained elusive. Recent studies have shown that GC could directly injure the blood ve...
Main Authors: | Xudong Yao, Shengnan Yu, Xingzhi Jing, Jiachao Guo, Kai Sun, Fengjing Guo, Yaping Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-020-01658-y |
Similar Items
-
Inhibition of MAGL activates the Keap1/Nrf2 pathway to attenuate glucocorticoid‐induced osteonecrosis of the femoral head
by: Ning Yang, et al.
Published: (2021-06-01) -
Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head
by: Huachen Yu, et al.
Published: (2020-04-01) -
Icariin Protects against Glucocorticoid-Induced Osteonecrosis of the Femoral Head in Rats
by: Zengfa Huang, et al.
Published: (2018-05-01) -
Osteonecrosis of the femoral head due to brucellosis: a case report
by: Peixu Wang, et al.
Published: (2020-03-01) -
The Protective Effect of Luteolin in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
by: Zijian Yan, et al.
Published: (2020-08-01)